Acute Lymphocytic Leukemia Market

•

0 likes•33 views

P

The total incident cases of Acute Lymphocytic Leukemia in the 7MM were 10,341 in 2017. It is being observed that around 56% of age-specific incident cases of ALL were found to be in the age group of <20 years in 2017. Also, ALL is more frequent in males as compared to females. The market size of Acute Lymphocytic Leukemia in the 7MM was found to be USD 1,246 Million in 2017. Increasing focus towards the development of targeted therapies, rising occurrence of ALL, improvement in the diagnosis and awareness, and competitive landscape are some of the key factors expected to drive the ALL market in the coming years. The key players in the Acute Lymphocytic Leukemia market includes Pharmacyclics, Takara Bio/ Otsuka, Jazz Pharmaceutical, Bellicum Pharmaceuticals, Precision BioSciences, Allogene Therapeutics, Novartis, Autolus, Janssen Pharmaceuticals, Gamida Cell, BioLineRx, Bristol-Myers Squibb, Pfizer, Fate Therapeutics, Gilead Sciences, Sanofi, TCR2 Therapeutics, Miltenyi Biotec, AbbVie and others. For more detailed information on Acute Lymphocytic Leukemia Market, visit: https://www.delveinsight.com/report-store/acute-lymphocytic-leukemia-all-market

Acute Lymphocytic Leukemia Market

More Related Content

More from pharmdelve

Gender Dysphoria is the feeling of discomfort or distress that might occur in people whose gender identity differs from their sex assigned at birth or sex-related physical characteristics. In 2017, the therapeutic market of Gender Dysphoria in 7MM was USD 102.73 million. As per the Delveinsight, the total prevalent population of Gender Dysphoria in the 7MM was 37,241 in 2017. The prevalence of Gender Dysphoria in the United States was found to be 12,521, while the UK and France had a prevalence of 8,214 and 1,544, respectively. The absence of therapies in the market, increase in the affected population, poor efficacy, and side effects associated with current therapies are some of the key factors expected to drive the Gender Dysphoria market forward in the coming years. Source: Gender Dysphoria Market

Gender Dysphoria Market

Gender Dysphoria Market

Gender Dysphoria Market

Prurigo Nodularis (PN) is an intensely pruritic, chronic skin condition characterized by localized or generalized hyperkeratotic papules and nodules typically in a symmetrical distribution. As per the Delveinsight, in 2017, the market size of Prurigo Nodularis in 7MM was USD 659.29 Million. The total diagnosed prevalent population of Prurigo Nodularis in 7MM was 539,893 in 2017. Among the 7MM, the United States had the largest share of the total diagnosed prevalent population with ~46.30% of the total cases. Government initiatives, pipeline advancements and various off-label therapies, growth in R&D and increase in the number of patients are the key drivers for Prurigo Nodularis Market. The key companies in the Prurigo Nodularis Market includes Menlo Therapeutics, Trevi Therapeutics, Galderma, Amgen, Maruho, Kiniksa Pharmaceuticals, Sanofi, Regeneron Pharmaceuticals and many others. Source: Prurigo Nodularis Market For more information on Prurigo Nodularis Market, visit: https://www.delveinsight.com/report-store/prurigo-nodularis-market

Prurigo Nodularis Market

Prurigo Nodularis Market

Prurigo Nodularis Market

Glioblastoma Multiforme (GBM) is the most frequently occurring type of primary tumors of the central nervous system (CNS) mostly in adults. As per the Delveinsight, the market size of Glioblastoma Multiforme in the 7MM (i.e United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) was USD 1,005 Million in 2017. The total diagnosed incident population of Glioblastoma Multiforme in seven major markets was 28,259 in 2017. It is observed that GBM is more prevalent among males than females in 7MM. Robust pipeline activity, upcoming launches and approval, improved treatment deliverance, emergence of immunotherapies, advancements in genomics and proteomics, low cost of treatment, interventions that can cross the blood-brain-barrier are some of the key driver for the Glioblastoma Multiforme Market. The key companies in the Glioblastoma Multiforme market includes VBL Therapeutics, Diffusion Pharmaceuticals, Bayer, MedImmune, DNAtrix, Oncoceutics, Karyopharm Therapeutics, VBI Vaccines, Kazia Therapeutics, Aivita Biomedical, Medicenna Therapeutics, Kintara Therapeutics, Immunomic Therapeutics and Inovio Pharmaceuticals. Source: Glioblastoma Multiforme (GBM) Market For more information on Glioblastoma Multiforme (GBM) Market, visit: https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market

Glioblastoma Multiforme Market

Glioblastoma Multiforme Market

Glioblastoma Multiforme Market

Cystic Fibrosis is a life-limiting autosomal recessive genetic disorder that severely damages the lungs and the digestive system. As per the Delveinsight, the total prevalent population of Cystic Fibrosis in 6MM was 61,306 in 2017. The prevalent population of Cystic Fibrosis in the UK was 10,468, while the US and Spain had a prevalent population of 30,139 and 2,075 respectively in 2017. The Cystic Fibrosis market Size in the 6MM was found to be USD 1,940.1 million in 2017. High number of drugs in the pipeline, better diagnostic techniques, most frequent mutation, and increased Research Funding are some of the key factors expected to drive the Cystic Fibrosis market forward in the coming years. Some of the key companies in the Cystic Fibrosis market include Translate Bio, Proteostasis Therapeutics, Vertex Pharmaceuticals, Arrowhead Pharmaceuticals, ProQR Therapeutics, Ionis Pharmaceuticals, Verona Pharmaceuticals, Eloxx Pharmaceuticals, and many others. For more details, visit: https://www.delveinsight.com/report-store/cystic-fibrosis-market Source : Cystic Fibrosis Market Analysis

Cystic Fibrosis Market

Cystic Fibrosis Market

Cystic Fibrosis Market

In 2017, the total prevalent population of Epidermolysis Bullosa in 7MM was 41,509. The prevalent cases of Epidermolysis Bullosa in the United States was 26,104 in 2017, while the United Kingdom and Germany had 5,037 and 4,919 prevalent cases respectively. The market size of Epidermolysis Bullosa in 7MM USD 2,283.40 million in 2017. Robust pipeline, increase in funding for accelerating the development of novel therapies for Epidermolysis Bullosa treatment and encouraging organizations to develop promising therapies are some of the key factors expected to drive the Epidermolysis Bullosa Market forward in the coming years. The key players in the Epidermolysis Bullosa Market includes Amryt Pharma, Abeona Therapeutics, Castle Creek Pharmaceuticals, RegeneRx, Krystal Biotech, Fibrocell Technologies, Castle Creek Pharmaceuticals, RHEACELL GmbH, Holostem Terapie Avanzate, StemRim, Shionogi, Menlo Therapeutics and Phoenix Tissue Repair. For more detailed information on Epidermolysis Bullosa Market, visit: https://www.delveinsight.com/report-store/epidermolysis-bullosa-market

Epidermolysis Bullosa Market

Epidermolysis Bullosa Market

Epidermolysis Bullosa Market

Osteosarcoma Market In 2017, the total incident population of Osteosarcoma in 7MM was 2,181. The incident cases of Osteosarcoma in the United States was found to be 1,141 in 2017. The therapeutic market of Osteosarcoma in 7MM was found to be USD 72.50 million in 2017. Robust pipeline, increase in incidence and more Immunotherapies into clinical trials are some of the key factors expected to drive the Osteosarcoma Market forward in the coming years. The key players in the Osteosarcoma Market includes Bayer, Exelixis, Nektar Therapeutics, Eisai, Y-mAbs Therapeutics, GlaxoSmithKline, Novartis, Aadi Bioscience, Vaccinex, Inc., Eleison Pharmaceuticals, Aurora biopharma, BioAtla, Iovance Biotherapeutics, Isofol Medical AB, Bristol-Myers Squibb and Cellestia Biotech. For more detailed information on Osteosarcoma Market, visit: https://www.delveinsight.com/report-store/osteosarcoma-market

Osteosarcoma Market

Osteosarcoma Market

Osteosarcoma Market

In 2017, the total prevalent population of Cervical Cancer in 7MM was 43,514. The prevalent cases of Cervical Cancer in the United States in 2017 was 32.07% of the total prevalent cases. The therapeutic market of Cervical Cancer in the 7MM was found to be USD 330.59 million in 2017. Advancements in treatment, improvement in preventive measures, and early detection of disease are some of the key factors expected to drive the Cervical Cancer Market forward in the coming years. The key players in the Cervical Cancer Market includes Seattle Genetics, Genmab, AstraZeneca, Zeria Pharmaceutical, Regeneron Pharmaceutical, Sanofi, Advaxis, Iovance Biotherapeutics, Agenus, Roche, Akeso Biopharma, Vaccibody and Altor BioScience. For more detailed information on Cervical Cancer Market, visit: https://www.delveinsight.com/infographics/cervical-cancer-market

Cervical Cancer Market

Cervical Cancer Market

Cervical Cancer Market

In 2017, the total incident cases of Multiple Myeloma in 8MM was 85,971. The incident cases of Multiple Myeloma in the United States was found to be 30,271 in 2017. The market size of Multiple Myeloma in 8MM was USD 14,111 million in 2017. Increasing incidence rate, high adoption rate of newer therapies and an increase in the Geriatric Population are some of the key market drivers for Multiple Myeloma. The key players in the Multiple Myeloma Market includes GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, AbbVie, Roche, Janssen Biotech, Nanjing Legend Biotech, Oncopeptides AB, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Celgene, RAPA Therapeutics, Pfizer, Cellectar Biosciences, BioLineRx, Aduro Biotech, ExCellThera, Takeda, Glenmark, Poseida Therapeutics, Amgen, Precision BioSciences, Juno Therapeutics, Molecular Partners AG, Cartesian Therapeutics, AstraZeneca, MorphoSys AG, I-Mab Biopharma and Chipscreen Biosciences. For more detailed information on Multiple Myeloma Market, visit: https://www.delveinsight.com/report-store/multiple-myeloma-market

Multiple Myeloma Market

Multiple Myeloma Market

Multiple Myeloma Market

The total prevalent population of Cutaneous Lupus Erythematosus in the 7MM was 327,569 in 2017. The Cutaneous Lupus Erythematosus cases in the United States in 2017 was 182,765. The Market Size of Cutaneous Lupus Erythematosus in 7MM was found to be USD 485.27 Million in 2017, according to DelveInsight, Cutaneous Lupus Erythematosus Market in the 7MM is expected to change during the study period. Rising prevalence and awareness of the disease, refined clinical trial design, contemporary advances in R&D are some of the key factors expected to drive the cutaneous lupus erythematosus market forward in the coming years. Some of the key players in the Cutaneous Lupus Erythematosus market include Biogen, Pfizer, Galapagos NV, Gilead Sciences, LEO Pharma/ Japan Tobacco, VIELABIO and many others. For more detailed information on Cutaneous Lupus Erythematosus market, visit: https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-market

Cutaneous Lupus Erythematosus Market

Cutaneous Lupus Erythematosus Market

Cutaneous Lupus Erythematosus Market

In 2017, the total prevalent cases of Uveitis in the United States were 357,791. It was found that in the United States, Acute Anterior Uveitis accounted for 43% of the total cases of Uveitis in 2017. The market size of Uveitis in the seven major markets (i.e the US, Germany, France, Italy, the UK, Spain and Japan) was found to be USD 1,045.9 Million in 2017, which is expected to increase during the forecast period. Availability of ocular inserts, orphan drug status, introduction of biologic drugs, and rich emerging pipeline with diverse ROA and MOA are some of the key factors expected to drive the Uveitis market forward in the coming years. The key players in the Uveitis market includes Aldeyra Therapeutics, Santen Pharmaceutical, Oculis, EyeGate Pharma, Novartis, Clearside Biomedical, Bristol-Myers Squibb, Sanofi, Eyevensys and many others. For more details visit: https://www.delveinsight.com/report-store/uveitis-market

Uveitis Market

Cytokine Release Syndrome Market The total number of patients who developed Cytokine Release Syndrome in the 7MM were 31 in 2017. The market size of Cytokine Release Syndrome (CRS) in the seven major markets was found to be USD 0.16 Million in 2017. Increasing incidence of Acute Cytokine Release Syndrome (CRS), increasing R&D activities, and non-competitive landscape are some of the key factors expected to drive the Cytokine Release Syndrome market in the upcoming years. The key pharma companies in the Cytokine Release Syndrome (CRS) market includes Novartis, Swedish Orphan Biovitrum (Sobi), Incyte Corporation, Jazz pharmaceuticals, CytoSorbents and many others. For more detailed information on Cytokine Release Syndrome Market, visit: https://www.delveinsight.com/report-store/cytokine-release-syndrome-market #inflammatorysyndrome #Cytokinereleasesyndrome #CRS #inflammation #systemicinflammatoryresponsesyndrome #sHLH

Cytokine Release Syndrome Market

Cytokine Release Syndrome Market

Cytokine Release Syndrome Market

The total incident cases of Prosthetic Joint Infection in 7MM and China was 66,811 in 2017. It has been observed that Males are more affected with PJI as compared to females. The market size of Prosthetic Joint Infection in the seven major markets and China was found to be USD 61.63 Million in 2017. Increasing number of joint arthroplasties, rapid technology development in china, favourable environment for anti-infective modalities, advancement in human genomics are some of the key factors expected to drive the Prosthetic Joint Infection market in the upcoming years. The key players in the Prosthetic Joint Infection market include Arrevus, TenNor Therapeutics, ContraFect Corporation, Peptilogics, Joint Purification Systems, and others. For more detailed information on Prosthetic Joint Infection Market, visit: https://www.delveinsight.com/report-store/prosthetic-joint-infection-market

Prosthetic Joint Infection Market

Prosthetic Joint Infection Market

Prosthetic Joint Infection Market

The market size of Immune Thrombocytopenia in 7MM was USD 2527.72 Million in 2017. The total prevalent population of Immune Thrombocytopenia in the 7MM is estimated to be approximately 184,676 in 2020. The key players in the Immune Thrombocytopenia market include Octapharma USA, Amgen, CSL Behring, Dova Pharmaceuticals, Rigel Pharmaceuticals, Novartis, Bio Products Laboratory, Takeda, AstraZeneca, Biotest, SK Plasma, Argenx, Kezar Life Sciences, UCB Biopharma, Bristol-Myers Squibb, Principia Biopharma, Protalex and others. For more detailed information visit: https://www.delveinsight.com/report-store/immune-thrombocytopenia-market

Immune Thrombocytopenia Market

Immune Thrombocytopenia Market

Immune Thrombocytopenia Market

The market size of Acute Kidney Injury in the United States was USD 2,907 Million in 2017. The United States recorded 895,078 cases of Acute Kidney Injury in 2017, while Germany had registered around 82,902 diagnosed cases during the same period. The key companies in the Acute Kidney Injury market include Exponential Biotherapies, Alloksys, Angion Biomedica Corp, Quark Pharmaceuticals, AM Pharma, Atox Bio, Astellas Pharma, Orion Pharma, MediBeacon, Pharming and others. For more detailed information visit at: https://www.delveinsight.com/report-store/acute-kidney-injury-aki-market#infographics

Acute Kidney Injury Market

Acute Kidney Injury Market

Acute Kidney Injury Market

The market size of Hemophilia A was found to be USD 6,266 Million in 2017. The total diagnosed and treated a prevalent population of Hemophilia A was found to be 38,212 in 2017 (in the 7 MM). The popularity of Gene Therapy, Development of Novel Treatments with an extended half-life, and Increased Focus on Prophylactic Treatment are some of the leading factors expected to drive the Hemophilia A market in the coming years. The key players in the Hemophilia A market include Biomarin Pharmaceutical, Novo Nordisk, Sanofi, Pfizer, Catalyst Biosciences, OPKO Biologics, Spark Therapeutics, Sangamo therapeutics and others. For more details visit: https://www.delveinsight.com/report-store/hemophilia-a2030-market #hemophilia #medicine #treatment #prophylaxis #hemophilia #patients #geneticdisorder #geneticdisease

Hemophilia A Market

Hemophilia A Market

Hemophilia A Market

According to #DelveInsight, the #Market Size of Diabetic Gastroparesis is expected to reach USD 4331.47 Million by 2030 (in 7 Major Markets). Increased awareness, #UntappedMarket, Novel #therapeutics options, and Advances in Continuous #Glucose Monitoring #CGMM) #techniques are some of the factors expected to drive the #DiabeticGastroparesis market in the upcoming years. Key Players involved in the Diabetic Gastroparesis market include Allergan, Evoke Pharma, Theravance Biopharma US, Inc., Censa Pharmaceuticals Inc., #CinDomePharma and others. For more details visit: https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size #diabeticgastroparesis #diabetes #gastroparesis #gastrointestinal #pharmaceutical #biotechnology #healthcare #market #marketresearch #lifesciences

Diabetic gastroparesis market

Diabetic gastroparesis market

Diabetic gastroparesis market

Diabetic Peripheral Neuropathy Market

Diabetic Peripheral Neuropathy Market

Diabetic Peripheral Neuropathy Market

Rare Disease

Hepatitis Market

Hepatitis Market

Hepatitis Market

Cyclin-Dependent Kinase

Cyclin-Dependent Kinase

Cyclin-Dependent Kinase

More from pharmdelve (20)

Gender Dysphoria Market

Gender Dysphoria Market

Gender Dysphoria Market

Prurigo Nodularis Market

Prurigo Nodularis Market

Prurigo Nodularis Market

Glioblastoma Multiforme Market

Glioblastoma Multiforme Market

Glioblastoma Multiforme Market

Cystic Fibrosis Market

Cystic Fibrosis Market

Cystic Fibrosis Market

Epidermolysis Bullosa Market

Epidermolysis Bullosa Market

Epidermolysis Bullosa Market

Osteosarcoma Market

Osteosarcoma Market

Osteosarcoma Market

Cervical Cancer Market

Cervical Cancer Market

Cervical Cancer Market

Multiple Myeloma Market

Multiple Myeloma Market

Multiple Myeloma Market

Cutaneous Lupus Erythematosus Market

Cutaneous Lupus Erythematosus Market

Cutaneous Lupus Erythematosus Market

Uveitis Market

Cytokine Release Syndrome Market

Cytokine Release Syndrome Market

Cytokine Release Syndrome Market

Prosthetic Joint Infection Market

Prosthetic Joint Infection Market

Prosthetic Joint Infection Market

Immune Thrombocytopenia Market

Immune Thrombocytopenia Market

Immune Thrombocytopenia Market

Acute Kidney Injury Market

Acute Kidney Injury Market

Acute Kidney Injury Market

Hemophilia A Market

Hemophilia A Market

Hemophilia A Market

Diabetic gastroparesis market

Diabetic gastroparesis market

Diabetic gastroparesis market

Diabetic Peripheral Neuropathy Market

Diabetic Peripheral Neuropathy Market

Diabetic Peripheral Neuropathy Market

Rare Disease

Hepatitis Market

Hepatitis Market

Hepatitis Market

Cyclin-Dependent Kinase

Cyclin-Dependent Kinase

Cyclin-Dependent Kinase

Recently uploaded

What can we really do to give meaning and momentum to equality, diversity and...

What can we really do to give meaning and momentum to equality, diversity and...

What can we really do to give meaning and momentum to equality, diversity and...

Storage_of _Bariquin_Components_in_Storage_Boxes.pptx

Storage_of _Bariquin_Components_in_Storage_Boxes.pptx

Storage_of _Bariquin_Components_in_Storage_Boxes.pptx

Master the Art of Yoga with Joga Yoga Training

Master the Art of Yoga with Joga Yoga Training

Master the Art of Yoga with Joga Yoga Training

Joga Yoga Training

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...

Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...

Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...

Psoriasis is an inflammatory skin disease that is associated with multiple comorbidities and substantially diminishes patients' quality of life. Topical therapies remain the cornerstone for treating mild psoriasis. Therapeutic advancements for moderate to severe plaque psoriasis include biologics that inhibit TNF-α, p40IL-12/23, IL-17, and p19IL-23, as well as an oral phosphodiesterase 4 inhibitor.

Management of psoriasis.pptx (Recent advances)

Management of psoriasis.pptx (Recent advances)

Management of psoriasis.pptx (Recent advances)

DR. MOHNISH SEKAR

Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...

Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...

Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...

Virtual Health Platforms_ Revolutionizing Patient Care.pdf

Virtual Health Platforms_ Revolutionizing Patient Care.pdf

Virtual Health Platforms_ Revolutionizing Patient Care.pdf

A balanced diet significantly influences dental health. This document highlights the impact of various nutrients on teeth and gums, the detrimental effects of sugary and acidic foods, and the benefits of vitamins and minerals. It provides practical tips for incorporating dental-friendly foods into daily meals and offers guidance on avoiding harmful dietary habits. The goal is to help readers improve their dental hygiene through informed eating choices.

Importance of Diet on Dental Health.docx

Importance of Diet on Dental Health.docx

Importance of Diet on Dental Health.docx

Male patients confined to bed usually prefer to use the urinal for voiding. The use of a urinal in the standing position facilitates emptying of the bladder If the patient is unable to stand, the urinal may be used in bed. Patients may also use a urinal in the bathroom to facilitate measurement of urinary output. Provide skin care and perineal hygiene after urinal use and maintain a professional manner EQUIPMENT Urinal with end cover (usually attached) Toilet tissue Clean gloves Additional PPE, as indicated ASSESSMENT Assess the patient’s normal elimination habits. Determine why the patient needs to use a urinal, such as a physician’s order for strict bed rest or immobilization. Assess the patient’s degree of limitation and ability to help with activity Assess for activity limitations, such as hip surgery or spinal injury, which would contraindicate certain actions by the patient. Check for the presence of drains, dressings, intravenous fluid infusion sites/equipment, traction, or any other devices that could interfere with the patient’s ability to help with the procedure or that could become dislodged. Assess the characteristics of the urine and the patient’s skin. Document the patient’s tolerance of the activity. Record the amount of urine voided on the intake and output record, if appropriate. Document any other assessments, such as unusual urine characteristics or alterations in the patient’s skin. SPECIAL CONSIDERATION Urinal should not be left in place for extended periods because pressure and irritation to the patient’s skin can result. If patient is unable to use alone or with assistance, consider other interventions, such as commode or external condom catheter. It may be necessary to assist patients who have difficulty holding the urinal in place, such as those with limited upper extremity movement or alteration in mentation, to prevent spillage of urine. The urinal may also be used standing or sitting at the bedside or in the patient’s bathroom, if patient is able to do so.

ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx

ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx

ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx

AnushriSrivastav

Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..

Overcome Your Phobias with Hypnotherapy.pptx

Overcome Your Phobias with Hypnotherapy.pptx

Overcome Your Phobias with Hypnotherapy.pptx

renewlifehypnosis

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

Stewardship is the act of taking good care of something. Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms. WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels. ACCORDING TO apic.org, Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms. ACCORDING TO pewtrusts.org, Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate According to WHO, Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis. Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance. According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites VISION Being proactive Supporting optimal animal and human health Exploring ways to reduce overall use of antimicrobials Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way GOAL to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come. being to preserve human and animal health and the effectiveness of antimicrobial medications. to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory to prevent antimicrobial overuse, misuse and abuse. to minimize the developme

Antibiotic Stewardship by Anushri Srivastava.pptx

Antibiotic Stewardship by Anushri Srivastava.pptx

Antibiotic Stewardship by Anushri Srivastava.pptx

AnushriSrivastav

CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations. Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences. The Promise: CRISPR offers exciting possibilities: Gene Therapy: Correcting genetic diseases like cystic fibrosis. Agriculture: Engineering crops resistant to pests and harsh environments. Research: Studying gene function to unlock new knowledge. The Peril: Ethical concerns demand attention: Off-target Effects: Unintended DNA edits can have unforeseen consequences. Eugenics: Misusing CRISPR for designer babies raises social and ethical questions. Equity: High costs could limit access to this potentially life-saving technology. The Path Forward: Responsible development is crucial: International Collaboration: Clear guidelines are needed for research and human trials. Public Education: Open discussions ensure informed decisions about CRISPR. Prioritize Safety and Ethics: Safety and ethical principles must be paramount. CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

Integrated Mother and Neonate Childwood Illness Health Care

Integrated Mother and Neonate Childwood Illness Health Care

Integrated Mother and Neonate Childwood Illness Health Care

Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...

Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...

Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...

A home-based pelvic floor muscle training and bladder training in women with urinary incontinence showed that combined pelvic floor muscle training and bladder training decreased the symptoms and improved the quality of life To strengthen your pelvic floor muscles, squeeze the muscles up to 10 times while standing, sitting or lying down. Do not hold your breath or tighten stomach, bottom or thigh muscles at the same time. When you get used to doing pelvic floor exercises, you can try holding each squeeze for one second

PT MANAGEMENT OF URINARY INCONTINENCE.pptx

PT MANAGEMENT OF URINARY INCONTINENCE.pptx

PT MANAGEMENT OF URINARY INCONTINENCE.pptx

Damage to the spinal cord above the sacral region causes reflex incontinence. This condition causes loss of voluntary control of urination; but the micturition reflex pathway often remains intact, allowing urination to occur without sensation of the need to void Overflow incontinence occurs when a bladder is overly full and bladder pressure exceeds sphincter pressure, resulting in involuntary leakage of urine. Causes often include head injury; spinal injury; multiple sclerosis; diabetes; trauma to the urinary system; and postanesthesia sedatives/hypnotics, tricyclics, and analgesia Hyperreflexia, a life-threatening problem affecting heart rate and blood pressure, is caused by an overly full bladder. It is usually neurogenic in nature; however, it can be caused functionally by blockage Diseases that cause irreversible damage to kidney tissue result in end-stage renal disease (ESRD). uremic syndrome- An increase in nitrogenous wastes in the blood, marked fluid and electrolyte abnormalities, nausea, vomiting, headache, coma, and convulsions characterize this syndrome. As the uremic symptoms worsen, aggressive treatment is indicated for survival Nocturia - awakening to void one or more times at night An excessive output of urine is polyuria. . A urine output that is decreased despite normal intake is called oliguria. increased urine formation (diuresis) a stoma (artificial opening) Urinary Retention. Urinary retention is an accumulation of urine resulting from an inability of the bladder to empty properly. URINE OVERFLOW- The sphincter temporarily opens to allow a small volume of urine (25 to 60 mL) to escape. With retention a patient may void small amounts of urine 2 or 3 times an hour with no real relief of discomfort or may continually dribble urine. pain or burning during urination (dysuria) as urine flows over inflamed tissues blood-tinged urine (hematuria) Urinary incontinence is the involuntary leakage of urine that is sufficient to be a problem. It can be either temporary or permanent, continuous or intermittentUrinary elimination depends on the function of the kidneys, ureters, bladder, and urethra. Kidneys remove wastes from the blood to form urine. Ureters transport urine from the kidneys to the bladder. The bladder holds urine until the urge to urinate develops. Urine leaves the body through the urethra. All organs of the urinary system must be intact and functional for successful removal of urinary wastes. Intact efferent and afferent nerves from the bladder to the spinal cord and brain must be present INTAKE AND OUTPUT OF URINE Assess the patient’s average daily fluid intake. at home, ask him or her to estimate his or her intake by showing a measurement on a commonly used glass or cup Special receptacles (urimeters) that attach between indwelling catheters and drainage bags are a convenient means of accurately measuring urine volume. A urimeter holds 100 to 200 mL of urine. After measuring urine from a urimeter, drain the cylinder

Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx

Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx

Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx

AnushriSrivastav

HEAT WAVE presented by priya bhojwani..pptx

HEAT WAVE presented by priya bhojwani..pptx

HEAT WAVE presented by priya bhojwani..pptx

priyabhojwani1200

Recently uploaded (20)

What can we really do to give meaning and momentum to equality, diversity and...

What can we really do to give meaning and momentum to equality, diversity and...

What can we really do to give meaning and momentum to equality, diversity and...

Storage_of _Bariquin_Components_in_Storage_Boxes.pptx

Storage_of _Bariquin_Components_in_Storage_Boxes.pptx

Storage_of _Bariquin_Components_in_Storage_Boxes.pptx

Master the Art of Yoga with Joga Yoga Training

Master the Art of Yoga with Joga Yoga Training

Master the Art of Yoga with Joga Yoga Training

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx

Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...

Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...

Healthcare Companion Robots: Key Features and Functionalities, Benefits, Chal...

Management of psoriasis.pptx (Recent advances)

Management of psoriasis.pptx (Recent advances)

Management of psoriasis.pptx (Recent advances)

Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...

Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...

Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...

Virtual Health Platforms_ Revolutionizing Patient Care.pdf

Virtual Health Platforms_ Revolutionizing Patient Care.pdf

Virtual Health Platforms_ Revolutionizing Patient Care.pdf

Importance of Diet on Dental Health.docx

Importance of Diet on Dental Health.docx

Importance of Diet on Dental Health.docx

ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx

ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx

ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx

Overcome Your Phobias with Hypnotherapy.pptx

Overcome Your Phobias with Hypnotherapy.pptx

Overcome Your Phobias with Hypnotherapy.pptx

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

Antibiotic Stewardship by Anushri Srivastava.pptx

Antibiotic Stewardship by Anushri Srivastava.pptx

Antibiotic Stewardship by Anushri Srivastava.pptx

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf

Integrated Mother and Neonate Childwood Illness Health Care

Integrated Mother and Neonate Childwood Illness Health Care

Integrated Mother and Neonate Childwood Illness Health Care

Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...

Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...

Contact mE 👙👨‍❤️‍👨 (89O1183OO2) 💘ℂall Girls In MOHALI By MOHALI 💘ESCORTS GIRL...

PT MANAGEMENT OF URINARY INCONTINENCE.pptx

PT MANAGEMENT OF URINARY INCONTINENCE.pptx

PT MANAGEMENT OF URINARY INCONTINENCE.pptx

Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx

Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx

Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx

HEAT WAVE presented by priya bhojwani..pptx

HEAT WAVE presented by priya bhojwani..pptx

HEAT WAVE presented by priya bhojwani..pptx